Return On Equity of MIRA PHARMACEUTICALS, INC. from 31 Dec 2022 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
MIRA PHARMACEUTICALS, INC. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2022 to 30 Sep 2024.
  • MIRA PHARMACEUTICALS, INC. Return On Equity for the quarter ending 30 Sep 2024 was -337%, a 23% increase year-over-year.
  • MIRA PHARMACEUTICALS, INC. annual Return On Equity for 2023 was -403%, a 55% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

MIRA PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -337% +98% +23% 01 Jul 2024 30 Sep 2024
Q2 2024 -286% -2942% -111% 01 Apr 2024 30 Jun 2024
Q1 2024 -294% -3114% -110% 01 Jan 2024 31 Mar 2024
Q4 2023 -403% +486% +55% 01 Oct 2023 31 Dec 2023
Q3 2023 -436% 01 Jul 2023 30 Sep 2023
Q2 2023 2656% 01 Apr 2023 30 Jun 2023
Q1 2023 2821% 01 Jan 2023 31 Mar 2023
Q4 2022 -888% 01 Oct 2022 31 Dec 2022

MIRA PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 -403% +486% +55% 01 Jan 2023 31 Dec 2023
2022 -888% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.